KRISTEN FARQUHAR: Open Payments
NPI 1245707827 · LUBBOCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,218 in 69 payments from 14 companies in 2025. Trend: 2023 $1,629 · 2024 $1,189 · 2025 $1,218
Food & beverage: $1,205Education: $13
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 11 | $282 |
| Amgen Inc. | 7 | $158 |
| E.R. Squibb & Sons, L.L.C. | 19 | $157 |
| Janssen Biotech, Inc. | 11 | $151 |
| REVANCE THERAPEUTICS, INC. | 2 | $105 |
| Novartis Pharmaceuticals Corporation | 5 | $96 |
| Lilly USA, LLC | 4 | $83 |
| ABBVIE INC. | 3 | $48 |
| SpringWorks Therapeutics, Inc. | 1 | $29 |
| Organon LLC | 2 | $27 |
Products named: Bimzelx, TREMFYA, OTEZLA, Sotyktu, DAXXIFY, TALTZ, SKYRIZI, GOMEKLI.
Industry payments across TX — which companies pay providers there.
